Pharmaceutically active morpholinol

Details for Australian Patent Application No. 2002315922 (hide)

Owner Glaxo Group Limited

Inventors Morgan, Phillip Frederick; Musso, David Lee; Partridge, John Joseph

Agent Davies Collison Cave

Pub. Number AU-B-2002315922

Parent 23280

Filing date 11 December 2002

Wipo publication date 10 April 2003

Acceptance publication date 1 June 2006

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

9 January 2003 Complete Application Filed

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002315922

1 June 2006 Application Accepted

  Published as AU-B-2002315922

28 September 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002315923-Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis

2002315921-Molded tube of improved performance